Resorbable Adhesion Barrier Draft Guidance Calls For Randomized Trials

Randomized trials are recommended to minimize introduction of bias into studies of resorbable adhesion barriers for use in abdominal and/or pelvic surgery, FDA says in a recently released draft guidance on the devices.

More from Archive

More from Medtech Insight